Development Minister (): I would like to update
  the House on the UK’s contribution to the Seventh Replenishment
  of the Global Fund to Fight AIDS, Tuberculosis and Malaria (the
  Global Fund).
  The government has no doubt of the huge value and importance of
  the work of the Global Fund. The Foreign Secretary, the
  Chancellor, and I, have therefore very carefully considered our
  pledge to the seventh replenishment, balancing the needs of the
  fight against the three diseases with the many other demands on
  the aid budget. I would like to reassure the House that we have
  maintained communication with the Global Fund throughout.
  UK resilience, prosperity, and security depends on achieving our
  global health goals and supporting other countries, especially
  the least developed, to do the same. Countries with better health
  systems and healthier people are more likely to be stable and
  prosperous. The COVID-19 pandemic has shown how health
  emergencies can reverse countries’ economic and social progress –
  and how global health is a field where international cooperation
  is vital.
  The UK is a leader within this. We joined with others to create
  the Global Fund because we refused to accept the loss of millions
  of lives every year to diseases that were both preventable and
  treatable. It has proven its successful three-way partnership
  model between the private sector, civil society and governments
  and we are proud to have contributed over £4.4 billion to the
  Global Fund, and as third largest donor, to have been an
  important part of its success. Together we have cut the mortality
  rate of the three diseases by more than half, helping to save 50
  million lives, while improving access to prevention and
  treatment, building the strong and inclusive health systems that
  underpin all health services, and helping countries respond to
  the COVID-19 pandemic which threatens all these hard-won health
  development gains.
  However, a child still dies of malaria nearly every minute. Nine
  out of ten Commonwealth citizens still live in malaria endemic
  countries. AIDS is still the leading cause of death for young
  women across our Commonwealth and tuberculosis is a top leading
  infectious disease killer globally.
  We remain committed to the mission of the Global Fund. The UK
  will therefore contribute £1 billion to the seventh replenishment
  of the Global Fund, helping to save over 1.2 million lives and
  partnering with others to support implementation of its new
  strategy. This pledge is drawn from our current ODA allocation
  and, as well as helping to save lives and prevent over 28 million
  new cases and infections, this funding will also help to build
  strong and inclusive health systems and support countries to
  prepare for and prevent future pandemic threats, helping to build
  a better and safer world for everyone. It will make an important
  contribution to our priority of ending the preventable deaths of
  mothers, babies and children, helping to provide medicine for
  170,000 mothers to prevent transmitting HIV to their babies.
  The Global Fund is without question one of the most highly
  efficient and effective global health mechanisms in development.
  We owe it to both UK taxpayers and the communities it serves to
  demonstrate how and where the Fund performs with full openness
  and transparency. I will therefore be drawing up a UK-Global Fund
  performance agreement to help to reassure our taxpayers and
  professional interests that a strong and sustained focus on UK
  priorities such as strengthening health systems and putting
  health equity, gender and human rights are at the very core of
  the Global Fund’s work.
  We are proud of our record in global health. We have for decades
  worked at home and abroad to strengthen health systems, to
  improve nutrition, water, sanitation and hygiene, champion sexual
  and reproductive health and rights, improve access to vaccines
  and fight infectious diseases. We are one of the largest donors
  to the international COVID-19 response. We are a long-term funder
  of innovation, developing new technologies, generating the
  evidence to enable delivery at scale and promoting access for
  those who need it most.
  I would like to thank members across both Houses of Parliament
  for their invaluable advice, interest, and support on this
  investment.